DUBLIN–(BUSINESS WIRE)–The “Europe Single Cell Multiomics Market 2021-2031 by Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.
Europe single cell multiomics market was valued at $ 527.9 million in 2021 and will grow by 18.0% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
This 150-page report is based on a comprehensive research of the entire Europe single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.
Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Instruments
- Consumables
- Software
Based on Omics Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Single Cell Genomics (SCG)
- Single Cell Transcriptomics (SCT)
- Single Cell Proteomics (SCP)
- Single Cell Metabolomics (SCM)
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Clinical Research
- Oncology
- Cell Therapy
- Immunology
- Neurology
- Cell Biology
- Other Types of Clinical Research
- Translation Research
- Synthetic Biology
By Sample Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Human Samples
- Cancer Tissues
- Stem Cells
- Immune Cells
- Brain Cells
- Other Human Samples
- Animal Samples
- Microbial Samples
By Workflow, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Single-Cell Isolation and Dispensing
- Fluorescence-Activated Cell Sorting (FACS)
- Microfluidics
- Magnetic-Activated Cell Sorting (MACS)
- Random Seeding
- Manual Cell Picking
- Laser Capture Microdissection
- Other Technologies of Single-Cell Isolation and Dispensing
- Single-Cell Analysis
- Polymerase Chain Reaction
- Next-Generation Sequencing
- Mass Cytometry
- Mass Spectrometry
- Other Technologies of Single-Cell Analysis
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Research and Academic Laboratories
- Biopharmaceutical and Biotech Companies
- Contract Research Organizations (CROs)
- Other End Users
Geographically, the following national/local markets are fully investigated:
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
- 10x Genomics, Inc.
- 1CellBio, Inc.
- Becton, Dickinson and Company
- Berkeley Lights, Inc.
- BGI Genomics Co., Ltd.
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- BioTuring, Inc.
- Danaher Corporation (Cytiva Life Sciences)
- Dolomite Bio
- Fluidigm Corporation
- Fluxion Biosciences
- Illimina, Inc
- Mission Bio, Inc.
- Namocell, Inc.
- NanoString Technologies, Inc.
- Parse Biosciences, Inc.
- Proteona
- Qiagen N.V.
- RareCyte, Inc.
- Scipio Biosciences SAS
- Shilps Sciences
- Takara Bio Inc. (Takara Holdings)
- Thermo Fisher Scientific Inc.
Key Topics Covered:
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of Europe Market by Product Type
4 Segmentation of Europe Market by Omics Type
5 Segmentation of Europe Market by Application
6 Segmentation of Europe Market by Sample Type
7 Segmentation of Europe Market by Workflow
8 Segmentation of Europe Market by End User
9 European Market 2021-2031 by Country
10 Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/j16a7a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900